A Study to Evaluate Whether the Efficacy and Safety of Maraviroc Addition to Stable Antiretroviral Regimen in HIV Patients is Independent of The Patient's Age at Treatment Onset

Trial Profile

A Study to Evaluate Whether the Efficacy and Safety of Maraviroc Addition to Stable Antiretroviral Regimen in HIV Patients is Independent of The Patient's Age at Treatment Onset

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Jul 2016

At a glance

  • Drugs Maraviroc (Primary)
  • Indications HIV-1 infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 14 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top